Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Biogenesis logo — Accelerating clinical trials.

Biogenesis

Accelerating clinical trials.

Founded 2024 United States Palo Alto, United States 10 employees Seed Total: $2.75M Health Care, Pharmaceutical

General Information

Company Name Biogenesis
Founded Year 2024
Location United States Palo Alto, United States
Employees 10
Industries Health Care, Pharmaceutical
Funding Stage Seed
Business Model B2B, Platform, Marketplace
Revenue Model Subscription, Service Fee, Marketplace Fee
Social

BounceWatch is an independent company data service, not affiliated with Biogenesis. To contact Biogenesis, visit mybiogenesis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biogenesis compare?

A PDF of Biogenesis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biogenesis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biogenesis

Biogenesis, founded in 2024, is revolutionizing the Health Care and Pharmaceutical industries by accelerating clinical trials. With the slogan, "Accelerating clinical trials," the company leverages a robust ecosystem of high-performing trial sites across the US, APAC, and CEE, backed by direct EHR analytics. This strategic approach allows Sponsors and CROs to expedite study startups and deliver life-saving treatments more efficiently.

Biogenesis recently secured a $2.50M Seed Round investment on 01 March 2024, with leading contributions from Alt Capital and Greylock. This financial backing is expected to further propel their mission by expanding their network of high-enrolling sites and enhancing AI-powered feasibility tools, which boost operational efficiency. Positioned at the intersection of technology and healthcare, Biogenesis offers a compelling investment opportunity for those looking to impact the sector positively.

Business keywords: Clinical Trials, Site Selection, Patient Recruitment, ClinOps, Study Startup, AI-Powered Tools, EHR Analytics, High-Enrolling Sites, Feasibility Tools, Life-Saving Treatments, Healthcare Innovation, Sponsor-CRO Ecosystem

Services & Products

Feasibility Assessment
Site Intelligence and Analytics
Comprehensive Site Profiling
Clinical Study Optimization

Target Customers

Sponsors Contract Research Organizations (CROs) Clinical Research Sites

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $2.50M 2
Alt Capital, Greylock
01 Mar 2024
Pre Seed Round $250.00K 5
Kleiner Perkins Formic Ventures Pareto Holdings
Kleiner Perkins, Formic Ventures +3
02 Oct 2022

Biogenesis Alternatives & Competitors

View All Alternatives
Biogenesis vs
Inato
Inato France

Matching research sites to the right clinical trial protocols, unlocking site potential worldwide.

Series A
81 employees
AI, Health Care
Compare Biogenesis vs Inato
Biogenesis vs
Clariness
Clariness Germany

Supporting clinical trials worldwide through patient recruitment, study feasibility, surveys and ret...

182 employees
Health Care, Pharmaceutical
Biogenesis vs
BEKhealth
BEKhealth United States

AI to find the right patients, right now.

Venture round
28 employees
Health Care, IT
Compare Biogenesis vs BEKhealth
View all alternatives

FAQ About Biogenesis

Accelerating clinical trials.
Biogenesis was founded in 2024.
Biogenesis is headquartered in Palo Alto, United States.
Biogenesis operates in Health Care and Pharmaceutical. Its work centres on Clinical Trials, Site Selection, Patient Recruitment and ClinOps. Its customers include Sponsors, Contract Research Organizations (CROs) and Clinical Research Sites.
Biogenesis has a B2B, Platform and Marketplace business model. Its revenue comes from Subscription, Service Fee and Marketplace Fee.
Biogenesis has approximately 10 employees.
Biogenesis has completed 2 funding rounds, raising a total of $2.75M. The latest funding stage is Seed.
Biogenesis offers: Feasibility Assessment, Site Intelligence and Analytics, Comprehensive Site Profiling, Clinical Study Optimization.
Top alternatives and competitors to Biogenesis include Inato, Clariness, BEKhealth, Elligo Health Research. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biogenesis and Inato are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biogenesis, https://bouncewatch.com/company/biogenesis-trials, updated 4 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes